Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Welcome to ETFdb.com. Please help us personalize your experience.

Select the one that best describes you
  • ETF
  • PSCH
    Pricing Data
    $126.00
    Change: $0.02 (0.0%)
    Time: 10/15/18
    Previous Close: $125.98
  • Category
  • Health & Biotech Equities
  • ESG Score
Last Updated:

Profile

Vitals

Trading Data

Open: - Volume -
Day Lo - Day Hi -
  • 52 Week Lo: $88.83
  • 52 Week Hi: $145.25
  • AUM: $1,151.6 M
  • Shares: 9.2 M

Investment Themes

Historical Trading Data

  • 1 Month Avg. Volume: 151,559
  • 3 Month Avg. Volume: 159,298

Alternative ETFs in the Health & Biotech Equities Category

Sign Up for Pro to Unlock Data Sign Up
Type Ticker Expense Ratio Assets Avg. Daily Vol YTD Return
Cheapest
Largest (AUM)
Most Liquid (Volume)
Top YTD Performer

Analyst Report

This fund gives investors exposure to the small cap health care industry, a market segment that has both value and growth characteristics. Securities in this corner of the market can be also be prone to quick shifts in sentiment thanks to changing government regulations or policies. Furthermore, many companies in this corner of the market are unprofitable and rely on FDA drug approval in order to snap back into the green, a very risky proposition. With that being said, PSCH gives investors a nice mix of biotech, pharma, medical tech, and facility companies spreading risk around the various corners of the health care world. However, it should be noted that the fund does still have singificant concentrattion in its top ten holdings as these companies make up close to one third of total assets, rather high considering the fund only has 70 securities in total. As a result, investors should consider this fund only if they are looking to tactically tilt towards the sector or round out exposure to the health care segment.

Realtime Rating

Sign Up for Pro to Unlock Data Sign Up

Realtime Rating Summary

The adjacent table gives investors an individual Realtime Rating for PSCH on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Health & Biotech Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.

Compare to another ETF

View the Category Report

PSCH Overall Realtime Rating:

A+ Overall Rated ETF:

Metric Metric Realtime Rating A+ Metric Rated ETF
Liquidity B- n/a
Expenses A n/a
Performance
Volatility
Dividend
Concentration

Knowledge Centers

PSCH In-Depth Analysis

The following tables and charts contain in-depth metrics for this ETF and compare it to similar peer ETFs within its ETFdb.com Category.

PSCH Holdings

Filings Data as of: Oct 12, 2018

Concentration Analysis

This section compares how balanced and deep this ETF is relative to the peer group ETFdb.com Category.

Number of Holdings
Rank:
68
Category Low
Category High
% Assets in Top 10
Rank:
33.93%
Category Low
Category High
% Assets in Top 15
Rank:
45.86%
Category Low
Category High
% Assets in Top 50
Rank:
89.86%
Category Low
Category High

Asset Allocation

Asset Percentage
Common equity 100.0%
ETF Cash Component 0.0%

Sector Breakdown

Sector Percentage
Healthcare 97.42%
Other 2.58%
ETF Cash Component 0.0%

Market Cap Breakdown

Market Cap Percentage
Small cap 56.93%
Micro cap 40.59%
Mid cap 2.47%
ETF Cash Component 0.0%

Region Breakdown

Region Percentage
North America 97.53%
Europe 2.47%

Market Tier Breakdown

Region Percentage
United States 97.53%
Developed Markets (ex-US) 2.47%

Country Breakdown

Country Percentage
United States 97.53%
Ireland 2.47%

PSCH Expenses & Fees

This section compares the cost efficiency of this ETF to peers in the same ETFdb.com Category.

Sign Up for Pro to Unlock Data Sign Up

Expenses Ratio Analysis

ETF Average
0.548%
ETF Wtd. Average
0.21%
Category Average
0.47%
Expense Ratio
Rank:
0.29%
Category Low
Category High

Commission Free Trading

This ETF is not currently available for commission free trading on any platforms.

Category Commission Free Trading

There are 17 other ETFs in the Health & Biotech Equities ETFdb.com Category that are also eligible for commission free trading:

PSCH ESG Themes and Scores
  • 4.54
    ESG Score
  • 18.97%
    ESG Score Global Percentile (%)
  • 40.4%
    ESG Score Peer Percentile (%)
    • Revenue Exposure to Environmental Impact (%)

      Higher Improves ESG Score
    • Severe Environment Controversies (%)

      Higher Improves ESG Score
    • Sustainable Impact Solutions (%)
      0.66%

      Higher Improves ESG Score
    • Weighted Average Carbon Intensity (Tons of CO2e / $M Sales)
      23.85

      Lower Improves ESG Score
    • Fossil Fuel Reserves (%)

      Lower Improves ESG Score
    • High Impact Fossil Fuel Reserves (%)

      Lower Improves ESG Score
    • Water Stress High Risk Business Segment (%)

      Lower Improves ESG Score
    • Water Stress High Risk Geography (%)

      Lower Improves ESG Score
    • Water Stress Exposure Moderate (%)

      Lower Improves ESG Score
    • Water Stress Exposure High (%)

      Lower Improves ESG Score
    • Water Stress Exposure Low (%)

      Lower Improves ESG Score
    • Revenue Exposure to Energy Efficiency (%)

      Higher Improves ESG Score
    • Revenue Exposure to Alternative Energy (%)

      Higher Improves ESG Score
    • Revenue Exposure to Green Building (%)

      Higher Improves ESG Score
    • Revenue Exposure to Pollution Prevention (%)

      Higher Improves ESG Score
    • Revenue Exposure to Water Sustainability (%)

      Higher Improves ESG Score
    • Revenue Exposure to Social Impact (%)

      Higher Improves ESG Score
    • Sustainable Impact Solutions (%)
      0.66%

      Higher Improves ESG Score
    • ESG Exclusion Criteria (%)
      0.0%

      Higher Improves ESG Score
    • Revenue Exposure to Affordable Real Estate (%)

      Higher Improves ESG Score
    • Revenue Exposure to Education (%)

      Higher Improves ESG Score
    • Revenue Exposure to Major Disease Treatment (%)

      Higher Improves ESG Score
    • Revenue Exposure to Nutrition (%)

      Higher Improves ESG Score
    • Revenue Exposure to Sanitation (%)

      Higher Improves ESG Score
    • Revenue Exposure to SME Finance (%)

      Higher Improves ESG Score
    • Human Rights Norms Violation (%)

      Lower Improves ESG Score
    • Human Rights Norms Violation OR Watch List (%)

      Lower Improves ESG Score
    • Severe Human Rights Controversies (%)

      Lower Improves ESG Score
    • Labor Norms Violation (%)

      Lower Improves ESG Score
    • Labor Norms Violation OR Watch List (%)

      Lower Improves ESG Score
    • Severe Labor Controversies (%)

      Lower Improves ESG Score
    • Severe Customer Controversies (%)

      Lower Improves ESG Score
    • Global Compact Compliance Violation (%)

      Lower Improves ESG Score
    • Global Compact Compliance Violation OR Watch List (%)

      Lower Improves ESG Score
    • Catholic Values Fail (%)

      Lower Improves ESG Score
    • Islamic Non-Compliant (%)

      Lower Improves ESG Score
    • Adult Entertainment Involvement (%)

      Lower Improves ESG Score
    • Alcohol Involvement (%)

      Lower Improves ESG Score
    • Gambling Involvement (%)

      Lower Improves ESG Score
    • Nuclear Power Involvement (%)

      Lower Improves ESG Score
    • Tobacco Involvement (%)

      Lower Improves ESG Score
    • Weapons Involvement (%)

      Lower Improves ESG Score
    • Controversies Weapons Involvement (%)

      Lower Improves ESG Score
    • Civilian Firearms Involvement (%)

      Lower Improves ESG Score
    • Civilian Firearms Retailer (%)

      Lower Improves ESG Score
    • Civilian Firearms Producer (%)

      Lower Improves ESG Score
    • Direct Predatory Lending Involvement (%)

      Lower Improves ESG Score
    • Genetic Engineering Involvement (%)

      Lower Improves ESG Score
    • Severe Governance Controversies (%)

      Lower Improves ESG Score
    • Board Flag (%)

      Lower Improves ESG Score
    • Lack of Independent Board Majority (%)

      Lower Improves ESG Score
    • Board Independence (0-25%) (%)

      Lower Improves ESG Score
    • Board Independence (25-50%) (%)

      Lower Improves ESG Score
    • Board Independence (50-75%) (%)

      Lower Improves ESG Score
    • Board Independence (75-100%) (%)

      Lower Improves ESG Score
    • No Female Directors (%)

      Lower Improves ESG Score
    • Three OR More Female Directors (%)

      Lower Improves ESG Score
    • Females Represent 30% of Directors (%)

      Lower Improves ESG Score
    • Entrenched Board (%)

      Lower Improves ESG Score
    • Overboarding (%)

      Lower Improves ESG Score
    • Negative Director Votes (%)

      Lower Improves ESG Score
    • Ownership AND Control Flag (%)

      Lower Improves ESG Score
    • One Share One Vote (%)

      Lower Improves ESG Score
    • No Annual Director Elections (%)

      Lower Improves ESG Score
    • Does Not Use Majority Voting (%)

      Lower Improves ESG Score
    • Significant Votes Against Pay Practices (%)

      Lower Improves ESG Score
    • Controlling Shareholder (%)

      Lower Improves ESG Score
    • Controlling Shareholder Concerns (%)

      Lower Improves ESG Score
    • Cross Shareholdings (%)

      Lower Improves ESG Score
    • Poison Pill (%)

      Lower Improves ESG Score
    • Pay Flag (%)

      Lower Improves ESG Score
    • No Pay Performance Link (%)

      Lower Improves ESG Score
    • Lack of Internal Pay Equity (%)

      Lower Improves ESG Score
    • Executive Pay Non-Disclosure (%)

      Lower Improves ESG Score
    • Accounting Flag (%)

      Lower Improves ESG Score

PSCH Performance

This section shows how this ETF has performed relative to its peer group ETFdb.com Category.

1 Week Return
Rank:
-4.28%
Category Low
Category High
4 Week Return
Rank:
-10.20%
Category Low
Category High
13 Week Return
Rank:
-5.81%
Category Low
Category High
26 Week Return
Rank:
9.14%
Category Low
Category High
Year to Date Return
Rank:
27.89%
Category Low
Category High
1 Year Return
Rank:
37.91%
Category Low
Category High
3 Year Return
Rank:
95.91%
Category Low
Category High
5 Year Return
Rank:
159.17%
Category Low
Category High

PSCH Fund Flows

This section compares the fund flows of this ETF to peers in the same ETFdb.com Category.

1 Week Fund Flow
Rank:
‑$58.3 M
Category Low
Category High
4 Week Fund Flow
Rank:
‑$44.5 M
Category Low
Category High
13 Week Fund Flow
Rank:
$397.8 M
Category Low
Category High
26 Week Fund Flow
Rank:
$730.4 M
Category Low
Category High
Year to Date Fund Flow
Rank:
$829.9 M
Category Low
Category High
1 Year Fund Flow
Rank:
$853.8 M
Category Low
Category High
3 Year Fund Flow
Rank:
$795.9 M
Category Low
Category High
5 Year Fund Flow
Rank:
$832.6 M
Category Low
Category High

Brought to You by Mitre Media


Charts

The following charts can be customized to display historical performance in a number of different formats, including line charts, bar charts, and candlesticks. Time periods can be adjusted to increase or decrease the period shown, ranging from five minutes to several months.

The following chart also includes the option to compare the performance of PSCH relative to other ETFs and benchmarks or to include indicators such as Bollinger Bands, relative strength, and moving averages.

PSCH Valuation

This section shows how the P/E multiple of this ETF compares to the peer group ETFdb.com Category.

Sign Up for Pro to Unlock Data Sign Up
P/E Ratio
Rank:
38.07
Category Low
Category High

PSCH Dividend

This section shows how the dividend yield of this ETF compares to the peer group ETFdb.com Category.

Sign Up for Pro to Unlock Data Sign Up
Dividend
$0.01
Dividend Date
2018-09-24
Annual Dividend Rate
n/a
Annual Dividend Yield
Rank:
No Ranking Available
Category Low
Category High

PSCH Technicals

Sign Up for Pro to Unlock Data Sign Up

Volatility Analysis

This section shows how the volatility of this ETF compares to the peer group ETFdb.com Category.

5 Day Volatility
Rank:
23.57%
Category Low
Category High
20 Day Volatility
Rank:
15.03%
Category Low
Category High
50 Day Volatility
Rank:
14.13%
Category Low
Category High
200 Day Volatility
Rank:
14.86%
Category Low
Category High
Beta
Rank:
1.02
Category Low
Category High
Standard Deviation
Rank:
16.45%
Category Low
Category High

Technicals

  • 20 Day MA: $135.52
  • 60 Day MA: $137.69
  • MACD 15 Period: -7.75
  • MACD 100 Period: -8.67
  • Williams % Range 10 Day: 86.91
  • Williams % Range 20 Day: 89.60
  • RSI 10 Day: 15
  • RSI 20 Day: 26
  • RSI 30 Day: 34
  • Ultimate Oscillator: 30

Bollinger Brands

  • Lower Bollinger (10 Day): $123.65
  • Upper Bollinger (10 Day): $139.14
  • Lower Bollinger (20 Day): $125.35
  • Upper Bollinger (20 Day): $146.27
  • Lower Bollinger (30 Day): $127.25
  • Upper Bollinger (30 Day): $149.17

Support & Resistance

  • Support Level 1: $124.41
  • Support Level 2: $122.81
  • Resistance Level 1: $127.30
  • Resistance Level 2: $128.59

Stochastic

  • Stochastic Oscillator %D (1 Day): 36.01
  • Stochastic Oscillator %D (5 Day): 13.54
  • Stochastic Oscillator %K (1 Day): 28.65
  • Stochastic Oscillator %K (5 Day): 12.66

Fact Sheet

Fact sheets are issued by the ETF provider and framed by ETFdb.com. Information contained within the fact sheet is not guaranteed to be timely or accurate.

Source: LSEG Information Services (US), Inc. (“LSEG”) © LSEG 2016. All rights in the XTF data, ratings and / or underlying data contained in this communication (“the XTF information”) vest in LSEG and/or its licensors. Neither LSEG nor its licensors accept any liability arising out of the use of, reliance on or any errors or omissions in the XTF information. No further distribution of the XTF information is permitted without LSEG’s express written consent. LSEG does not promote, sponsor or endorse the content of this communication.

Copyright MSCI ESG Research LLC [2018]. All Rights Reserved. MSCI ESG Research LLC’s (“MSCI ESG”) Fund Metrics products (the “Information”) provide environmental, social and governance data with respect to underlying securities within more than 23,000 multi-asset class Mutual Funds and ETFs globally. MSCI ESG is a Registered Investment Adviser under the Investment Advisers Act of 1940. MSCI ESG materials have not been submitted, to nor received approval from, the US SEC or any other regulatory body. None of the information constitutes an offer to buy or sell, or a promotion or recommendation of, any security, financial instrument or product or trading strategy, nor should it be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. None of the Information can be used to determine which securities to buy or sell or when to buy or sell them. The Information is provided “as is” and the user of the Information assumes the entire risk of any use it may make or permit to be made of the Information. All Information is provided solely for your internal use, and may not be reproduced or redisseminated in any form without express prior written permission from MSCI. Neither MSCI ESG nor any of its affiliates or any third party involved in or related to creating any Information makes any express or implied warranties, representations or guarantees, and in no event will MSCI ESG or any such affiliate or third party have any liability for any direct, indirect, special, punitive, consequential or any other damages (including lost profits) relating to any Information. More information on MSCI ESG Fund Metrics, provided by MSCI ESG Research LLC, can be found at https://www.msci.com/esg-fund-metrics.
© 2018 Market data provided is at least 15-minutes delayed and hosted by Barchart Solutions.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use, please see disclaimer.